BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30704794)

  • 1. High occupational level is associated with poor response to the treatment of depression: A replication study.
    Mandelli L; Serretti A; Souery D; Mendlewicz J; Kasper S; Montgomery S; Zohar J
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):349-355. PubMed ID: 30704794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High occupational level is associated with poor response to treatment of depression.
    Mandelli L; Serretti A; Souery D; Mendlewicz J; Kasper S; Montgomery S; Zohar J
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1320-6. PubMed ID: 27211903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder.
    Lam RW; Iverson GL; Evans VC; Yatham LN; Stewart K; Tam EM; Axler A; Woo C
    J Affect Disord; 2016 Oct; 203():55-61. PubMed ID: 27280963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupational factors associated with major depressive disorder: A Brazilian population-based study.
    Oenning NSX; Ziegelmann PK; Goulart BNG; Niedhammer I
    J Affect Disord; 2018 Nov; 240():48-56. PubMed ID: 30053683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of occupation according to income on depressive symptoms in South Korean individuals: Findings from the Korean Welfare Panel Study.
    Kim W; Park EC; Lee TH; Ju YJ; Shin J; Lee SG
    Int J Soc Psychiatry; 2016 May; 62(3):227-34. PubMed ID: 26801073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived Stress among Different Occupational Groups and the Interaction with Sedentary Behaviour.
    Dėdelė A; Miškinytė A; Andrušaitytė S; Bartkutė Ž
    Int J Environ Res Public Health; 2019 Nov; 16(23):. PubMed ID: 31756951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle-associated health risk indicators across a wide range of occupational groups: a cross-sectional analysis in 72,855 workers.
    Väisänen D; Kallings LV; Andersson G; Wallin P; Hemmingsson E; Ekblom-Bak E
    BMC Public Health; 2020 Nov; 20(1):1656. PubMed ID: 33148214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Masked hypertension and effort-reward imbalance at work among 2369 white-collar workers.
    Boucher P; Gilbert-Ouimet M; Trudel X; Duchaine CS; Milot A; Brisson C
    J Hum Hypertens; 2017 Oct; 31(10):620-626. PubMed ID: 28639611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic impact of depression: resistance or severity?
    Fostick L; Silberman A; Beckman M; Spivak B; Amital D
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):671-5. PubMed ID: 20624674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study.
    Balestri M; Calati R; Souery D; Kautzky A; Kasper S; Montgomery S; Zohar J; Mendlewicz J; Serretti A
    J Affect Disord; 2016 Jan; 189():224-32. PubMed ID: 26451508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claim rates of compensable back injuries by age, gender, occupation, and industry. Do they relate to return-to-work experience?
    Gluck JV; Oleinick A
    Spine (Phila Pa 1976); 1998 Jul; 23(14):1572-87. PubMed ID: 9682314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of fatigue and energy on work functioning and impairment in patients with major depressive disorder treated with desvenlafaxine.
    Sarfati D; Evans VC; Tam EM; Woo C; Iverson GL; Yatham LN; Lam RW
    Int Clin Psychopharmacol; 2017 Nov; 32(6):343-349. PubMed ID: 28763344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment.
    Weisler RH; Ota A; Tsuneyoshi K; Perry P; Weiller E; Baker RA; Sheehan DV
    J Affect Disord; 2016 Nov; 204():40-7. PubMed ID: 27322768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of functional improvement in employed adults with major depressive disorder treated with desvenlafaxine.
    Lam RW; Endicott J; Hsu MA; Fayyad R; Guico-Pabia C; Boucher M
    Int Clin Psychopharmacol; 2014 Sep; 29(5):239-51. PubMed ID: 24583567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Upper Limb Function and Employment Status on Return to Work of Blue-Collar Workers after Stroke.
    Fukuda S; Ueba Y; Fukuda H; Kangawa T; Nakashima Y; Hashimoto Y; Ueba T
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2187-2192. PubMed ID: 31126785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between symptoms of dry eye syndrome and occupational characteristics: the Korean National Health and Nutrition Examination Survey 2010-2012.
    Lee JH; Lee W; Yoon JH; Seok H; Roh J; Won JU
    BMC Ophthalmol; 2015 Oct; 15():147. PubMed ID: 26511443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of remission status on work functioning in employed patients treated for major depressive disorder.
    Sarfati D; Stewart K; Woo C; Parikh SV; Yatham LN; Lam RW
    Ann Clin Psychiatry; 2017 Feb; 29(1):11-16. PubMed ID: 27901522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lack of association between components of metabolic syndrome and treatment resistance in depression.
    Sagud M; Mihaljevic-Peles A; Uzun S; Cusa BV; Kozumplik O; Kudlek-Mikulic S; Mustapic M; Barisic I; Muck-Seler D; Pivac N
    Psychopharmacology (Berl); 2013 Nov; 230(1):15-21. PubMed ID: 23579429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious life events among resistant and non-resistant MDD patients.
    Amital D; Fostick L; Silberman A; Beckman M; Spivak B
    J Affect Disord; 2008 Oct; 110(3):260-4. PubMed ID: 18262654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.